Matches 1 - 50 out of 265 1 2 3 4 5 6 >


Match Document Document Title
9040040 Enzyme combinations to reduce brain tissue swelling  
Tissue fixed charge density (FCD) is identified as another potential therapeutic target for reducing brain tissue swelling. Reduction of the FCD could reduce the thermodynamic force driving water...
9029115 Lipase variants for pharmaceutical use  
The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or...
9011964 Nano-encapsulated, controlled drug manufacturing process  
A mixed dose of a nanosized drug wherein at least one portion of the mixed dose comprises a core nanosized drug encapsulated in at least one layer of a protective material having the same core...
9011842 Use of proteases for gluten intolerance  
The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or...
8980252 Methods of treatment of schizophrenia  
Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for...
8940295 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes  
The present invention comprises methods and compositions for the reduction of oxalate in humans, and methods for the purification and isolation of recombinant oxalate reducing enzyme proteins. The...
8895282 Use of a substance for manufacturing of a medicament for treatment of common cold  
A method for treatment and/or prevention of common cold caused by rhinovirus, wherein a patient in need is treated with a medicament including a hydrogen peroxide producing enzyme.
8889119 Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy  
This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth...
8865160 Treatment of disease conditions via administration of DNA repair enzyme  
The present invention is directed to compositions and methods of preserving viability of islets of Langerhans for transplantation, and treating various diseases and other abnormal or pathological...
8846064 Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly  
A cosmetic and pharmaceutical formulation for rejuvenation and restoration of the skin, and methods of making this formulation. The cosmetic and pharmaceutical formulations comprise liposomes...
8846033 Dietary supplement  
The invention relates to a dietary supplement that promotes proper ingestion and proper digestion of animal and/or vegetable proteins. The supplement comprises an enzyme mixture containing...
8815233 Method for treating pervasive development disorders  
A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and...
8802729 Enzyme stabilized detergent compositions  
Biodegradable detergent compositions comprising enzymes and 1,3-propanediol are provided. The 1,3-propanediol in the composition is biologically derived and enhances the stability of the enzymes...
8802087 Pharmaceutical compositions of lipase-containing products, in particular of pancreation  
Orally administrable pharmaceutical compositions of lipase-containing products, particularly pancreatin and pancreatin-containing products, or of enzyme products which contain at least one lipase...
8784856 Meadowfoam-based bioherbicide products  
Particular aspects provide methods for converting glucosinolate in a glucosinolate-containing plant material to glucosinolate breakdown products (GBPs), comprising: providing an amount of...
8784884 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency  
Compositions of the present invention, comprising the combination of enterically coated and uncoated pancreatic enzyme-containing beads are useful for treating or preventing pancreatitis pain, and...
8778335 Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders  
A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in...
8772240 Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases  
Methods of preparing alpha-1-antiproteinase inhibitor and controlling the amount of des-lys alpha-1-antiproteinase inhibitor in the preparation, and compositions comprising the same, as well as...
8765144 Antigenic complex for the diagnosis and treatment of Porphyromonas gingivalis infection  
The present invention provides a purified multimeric complex from P. gingivalis. The complex comprises at least one domain from each of RgpA, Kgp and HagA, and has a molecular weight greater than...
8728467 Methods comprising serratia peptidase for inhibition of osteomyelitis  
Physiologically acceptable anti-biofilm compositions comprising Serratia peptidase and optionally one or more of bromelain, papain and a fibrinolytic enzyme. Additional components can include...
8728754 Use of proteins isolated from Pseudomonas to control molluscs  
Provided herein are proteins derived from Pseudomonas sp., particularly Pseudomonas protegens, compositions comprising said proteins and their use in controlling molluscidal activity.
8715994 Polypeptides having beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same  
The present invention relates to isolated polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and isolated polynucleotides...
8715647 Enzyme feed additive and animal feed including it  
The use is provided composition as a feed additive which comprises one or more endoglucanases, and 0-20% by weight, based upon the content of cellulase proteins in the composition, of a...
8709386 Method of making and using an alpha-glucanase composition to reduce or remove biofilm  
Isolated α-glucanases from Hypocrea tawa, Trichoderma reesei, and Trichoderma konilangbra are described, as well as oral care compositions containing the same. The oral care composition may be...
8709776 Polypeptides having beta-glucosidase activity and beta-xylosidase activity and polynucleotides encoding same  
The present invention relates to isolated polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and isolated polynucleotides...
8697425 Composite yeast suitable for high concentration alcohol fermentation  
The present invention relates to a composite yeast for high concentration alcohol fermentation, which includes thermostable Saccharomyces cerevisiae, acid protease, phytase, cellulose,...
8697066 Botulinum toxin compositions and methods  
Disclosed herein are methods of using extracellular matrix digesting enzymes and neurotoxins, such as a Clostridial neurotoxins, to treat various medical conditions, such as overactive bladder,...
8673972 Human papilloma virus as predictor of cancer prognosis  
Methods of treating a head and neck cancer are disclosed.
8637292 Polypeptides having feruloyl esterase activity and nucleic acids encoding the same  
The present invention relates to isolated polypeptides having esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs,...
8632769 Proteolytic enzyme formulations  
Preferred embodiments of the present invention relate to proteolytic enzyme formulations. More specifically, several embodiments relate to a proteolytic formulation to facilitate digestion,...
8613918 Method for treating pervasive development disorders  
A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and...
8609087 Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases  
Compounds and methods for designing and identifying compounds which inhibit TFPP-like aspartyl protease enzymes by targeting the aspartic acid residues of the active site or mimicking peptides...
8603464 Alkaline phosphatase to reduce weight gain or induce weight loss  
The present invention provides methods for using human placental alkaline phosphatase or an active derivative to reduce blood glucose level in a mammal. Treatment regimens provided by the...
8568712 Enzyme and prebiotic combinations for enhancing probiotic efficacy  
This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth...
8540983 Debriding composition from bromelain and methods of production thereof  
The present invention relates to a debriding composition obtained from bromelain and to methods of producing same. Particularly, the present invention relates to a debriding composition obtained...
8524226 Methods of prolonging patency of hemodialysis access  
The invention provides methods for treating an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue....
8431526 Compositions and methods for prion decontamination  
The invention relates to compositions and methods for prion degradation, decontamination or disinfection. The composition comprises an oxidizing agent, one or more proteases and a surfactant such...
8431122 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes  
The present invention comprises methods and compositions for the reduction of oxalate in humans, and methods for the purification and isolation of recombinant oxalate reducing enzyme proteins. The...
8404230 Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes  
Administration of an exogenous pulmonary surfactant in combination with antioxidant enzymes is effective for the prevention of bronchopulmonary dysplasia (BPD) and decreases the markers of...
8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells  
Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best...
8383101 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions  
Physiologically acceptable anti-biofilm compositions comprising Serratia peptidase and optionally one or more of bromelain, papain and a fibrinolytic enzyme. Additional components can include...
8333962 Controlled release multidrug formulations for spinal cord injury  
A controlled release multidrug formulation for improving locomotor recovery after spinal cord injury comprising: (a) a first composition comprising a first bioactive agent, encapsulated within a...
8333961 Natural liniment for treatment of skin cancers  
A liniment composition for reversing or retarding the growth of cancerous skin tumors comprising primarily, pancreatin, pepsin, betaine HCL, emulsified vitamin A, and zinc, pancrelipase,...
8298804 Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures  
The present invention relates to isolated structures containing degradative enzymes produced from a marine organism. The enzymes produced are based on the carbon source upon which the marine...
8293229 Methods of producing stable pancreatic enzyme compositions  
Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies....
8287858 Proteolytic enzyme formulations  
Preferred embodiments of the present invention relate to proteolytic enzyme formulations. More specifically, several embodiments relate a proteolytic formulation comprising fungal protease,...
8273348 Lipase variants for pharmaceutical use  
The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or...
8257694 Nutritional compositions for reducing oxidative damage  
A nutritional composition for reducing oxidative damage and lipid peroxidation in humans, while allowing for the oxidative reactions necessary to sustain vital biological functions. The...
8246951 Collagenolytic active enzyme containing compositions, and their use in the dental field  
The invention relates to a composition comprising at least one collagenolytic active enzyme with enzymatic activity at acidic pH for drilless enzymatic caries removal. Furthermore, the present...
8173120 Method of preventing reduced feed intake in animals and treatment of disease conditions  
The present invention relates to a method for substantially preventing a reduction in feed intake in an animal which occurs when said animal is administered an antibiotic, the method comprising...

Matches 1 - 50 out of 265 1 2 3 4 5 6 >